Key result
FDG PET-CT identifies highly hypermetabolic right atrial angiosarcoma with novel pancreatic and renal metastases.
Case Report (n=1)
No
FDG PET-CT is valuable in the initial workup of cardiac angiosarcoma for accurate staging and identifying rare metastatic sites.
Answers are grounded in this paper and cite their sources.
FDG PET-CT may detect occult metastases in cardiac angiosarcoma; hypothesis-generating and should not yet change practice.
Cardiac angiosarcoma is the most common primary cardiac sarcoma in adults. Primary cardiac tumors are rare and have nonspecific clinical presentation, thus making its diagnosis challenging. Clinically, patients present with advanced disease demonstrating metastatic disease at initial presentation itself. It commonly metastasizes to lung, liver, brain, and bone; however metastases to lymph nodes, adrenal glands, spleen and skin has also been seen. We describe a case of right atrial angiosarcoma with extensive visceral metastases involving brain, lungs, liver, pancreas, kidney, and lymph nodes, demonstrated on contrast-enhanced (18)F-fluoro-deoxyglucose positron emission tomography-computed tomography (FDG PET-CT). To the best of our knowledge metastases to pancreas and kidney have not been reported so far in the literature. With our report, we emphasize on the initial use of FDG PET-CT in workup of cardiac angiosarcoma for accurate staging and prognostication of this disease.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2014) conducted a case report in Right atrial angiosarcoma with widespread visceral metastases (n=1). FDG PET-CT was evaluated on Detection of primary tumor and metastases. FDG PET-CT successfully identified a highly hypermetabolic right atrial angiosarcoma (SUVmax 19.2) with extensive visceral metastases, including previously unreported pancreatic and renal involvement.
Synapse has enriched 10 related papers. Consider them for comparative context: